Financial statements Healancy Biomedical
Balance sheet of Healancy Biomedical
Company age:
Age:
15 y. 11 m. 20 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of HEALANCY BIOMEDICAL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 2 177,72 | 2 047,20 | 1 958,70 | 2 043,20 | 1 925,38 |
| A. Fixed assets | 1 565,38 | 1 565,38 | 1 565,38 | 1 565,38 | 1 565,38 |
| B. Current assets | 612,34 | 481,82 | 393,32 | 477,82 | 360,00 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 2 177,72 | 2 047,20 | 1 958,70 | 2 043,20 | 1 925,38 |
| A. Equity | 481,64 | -493,88 | -2 794,04 | -3 809,54 | -4 164,54 |
| B. Liabilities and provisions for liabilities | 1 696,08 | 2 541,08 | 4 752,74 | 5 852,74 | 6 089,92 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.